Literature DB >> 10352299

Lysosomal accumulation and recycling of lipopolysaccharide to the cell surface of murine macrophages, an in vitro and in vivo study.

C Forestier1, E Moreno, J Pizarro-Cerda, J P Gorvel.   

Abstract

In this study, we detailed in a time-dependent manner the trafficking, the recycling, and the structural fate of Brucella abortus LPS in murine peritoneal macrophages by immunofluorescence, ELISA, and biochemical analyses. The intracellular pathway of B. abortus LPS, a nonclassical endotoxin, was investigated both in vivo after LPS injection in the peritoneal cavity of mice and in vitro after LPS incubation with macrophages. We also followed LPS trafficking after infection of macrophages with B. abortus strain 19. After binding to the cell surface and internalization, Brucella LPS is routed from early endosomes to lysosomes with unusual slow kinetics. It accumulates there for at least 24 h. Later, LPS leaves lysosomes and reaches the macrophage cell surface. This recycling pathway is also observed for LPS released by Brucella S19 following in vitro infection. Indeed, by 72 h postinfection, bacteria are degraded by macrophages and LPS is located inside lysosomes dispersed at the cell periphery. From 72 h onward, LPS is gradually detected at the plasma membrane. In each case, the LPS present at the cell surface is found in large clusters with the O-chain facing the extracellular medium. Both the antigenicity and heterogenicity of the O-chain moiety are preserved during the intracellular trafficking. We demonstrate that LPS is not cleared by macrophages either in vitro or in vivo after 3 mo, exposing its immunogenic moiety toward the extracellular medium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10352299

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium.

Authors:  Elke Cario; Dennis Brown; Mary McKee; Kathryn Lynch-Devaney; Guido Gerken; Daniel K Podolsky
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

2.  MyD88, but not toll-like receptors 4 and 2, is required for efficient clearance of Brucella abortus.

Authors:  David S Weiss; Kiyoshi Takeda; Shizuo Akira; Arturo Zychlinsky; Edgardo Moreno
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation.

Authors:  R Vemulapalli; Y He; L S Buccolo; S M Boyle; N Sriranganathan; G G Schurig
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes.

Authors:  C Forestier; E Moreno; S Méresse; A Phalipon; D Olive; P Sansonetti; J P Gorvel
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

5.  The human tumor microbiome is composed of tumor type-specific intracellular bacteria.

Authors:  Deborah Nejman; Ilana Livyatan; Garold Fuks; Noam Shental; Ravid Straussman; Nancy Gavert; Yaara Zwang; Leore T Geller; Aviva Rotter-Maskowitz; Roi Weiser; Giuseppe Mallel; Elinor Gigi; Arnon Meltser; Gavin M Douglas; Iris Kamer; Vancheswaran Gopalakrishnan; Tali Dadosh; Smadar Levin-Zaidman; Sofia Avnet; Tehila Atlan; Zachary A Cooper; Reetakshi Arora; Alexandria P Cogdill; Md Abdul Wadud Khan; Gabriel Ologun; Yuval Bussi; Adina Weinberger; Maya Lotan-Pompan; Ofra Golani; Gili Perry; Merav Rokah; Keren Bahar-Shany; Elisa A Rozeman; Christian U Blank; Anat Ronai; Ron Shaoul; Amnon Amit; Tatiana Dorfman; Ran Kremer; Zvi R Cohen; Sagi Harnof; Tali Siegal; Einav Yehuda-Shnaidman; Einav Nili Gal-Yam; Hagit Shapira; Nicola Baldini; Morgan G I Langille; Alon Ben-Nun; Bella Kaufman; Aviram Nissan; Talia Golan; Maya Dadiani; Keren Levanon; Jair Bar; Shlomit Yust-Katz; Iris Barshack; Daniel S Peeper; Dan J Raz; Eran Segal; Jennifer A Wargo; Judith Sandbank
Journal:  Science       Date:  2020-05-29       Impact factor: 47.728

Review 6.  Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host.

Authors:  R Martin Roop; Jennifer M Gaines; Eric S Anderson; Clayton C Caswell; Daniel W Martin
Journal:  Med Microbiol Immunol       Date:  2009-09-22       Impact factor: 3.402

7.  Identification of the essential Brucella melitensis porin Omp2b as a suppressor of Bax-induced cell death in yeast in a genome-wide screening.

Authors:  Géraldine Laloux; Michaël Deghelt; Marie de Barsy; Jean-Jacques Letesson; Xavier De Bolle
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

8.  Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine.

Authors:  Juan Esteban Ugalde; Diego José Comerci; M Susana Leguizamón; Rodolfo Augusto Ugalde
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

Review 9.  The Role of Neutrophils in Brucellosis.

Authors:  Edgardo Moreno; Elías Barquero-Calvo
Journal:  Microbiol Mol Biol Rev       Date:  2020-10-14       Impact factor: 11.056

10.  Novel application of low pH-dependent fluorescent dyes to examine colitis.

Authors:  Kazuhiro Ishiguro; Takafumi Ando; Osamu Watanabe; Hidemi Goto
Journal:  BMC Gastroenterol       Date:  2010-01-15       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.